Abstract
Background: Cancer nanotechnology has become a prime field of investigations for the scientists nowadays. There are several nanocarrier systems used for effective cancer therapeutics and gold nanoparticles (GNPs/AuNPs) have become promising vehicles for the delivery of anticancer drugs into their targets. Gold nanoparticles (GNPs/AuNPs) have been explored for tumor targeting, tumor imaging, and photothermal therapy of cancer due to their unique physicohemical and optical characteristics.
Methods: We searched about recent research progress made in the field of gold nanoparticulate systems for effective elimination of cancer. Our main focus was on the use of gold nanoparticles (spherical), gold nanorods, and gold nanostars for improved cancer therapy.
Results: Gold nanoparticles are suited well for cancer therapeutics due to their higher biocompatibility and lesser toxicity. They can be utilized actively or passively both for the targeting of tumor cells.
Conclusion: Recently, gold nanoparticulates have been investigated preclinically for the treatment of cancer. Their clinical practice is still a challenge and it is necessary to carry out clinical practice of gold nanoparticles to make them available in the market. Future advancement in the field of gold nanoparticles will likely produce better results in cancer therapeutics.
Keywords: Biocompatibility, clinical, gold nanoparticles, nanotechnology, photothermal, cancer treatment.
Current Nanomedicine
Title:Gold Nanoparticles and their Applications in Cancer Treatment
Volume: 8 Issue: 3
Author(s): Shivani Verma, Puneet Utreja, Mahfoozur Rahman and Lalit Kumar*
Affiliation:
- I. K. Gujral Punjab Technical University, Jalandhar-Punjab 144601,India
Keywords: Biocompatibility, clinical, gold nanoparticles, nanotechnology, photothermal, cancer treatment.
Abstract: Background: Cancer nanotechnology has become a prime field of investigations for the scientists nowadays. There are several nanocarrier systems used for effective cancer therapeutics and gold nanoparticles (GNPs/AuNPs) have become promising vehicles for the delivery of anticancer drugs into their targets. Gold nanoparticles (GNPs/AuNPs) have been explored for tumor targeting, tumor imaging, and photothermal therapy of cancer due to their unique physicohemical and optical characteristics.
Methods: We searched about recent research progress made in the field of gold nanoparticulate systems for effective elimination of cancer. Our main focus was on the use of gold nanoparticles (spherical), gold nanorods, and gold nanostars for improved cancer therapy.
Results: Gold nanoparticles are suited well for cancer therapeutics due to their higher biocompatibility and lesser toxicity. They can be utilized actively or passively both for the targeting of tumor cells.
Conclusion: Recently, gold nanoparticulates have been investigated preclinically for the treatment of cancer. Their clinical practice is still a challenge and it is necessary to carry out clinical practice of gold nanoparticles to make them available in the market. Future advancement in the field of gold nanoparticles will likely produce better results in cancer therapeutics.
Export Options
About this article
Cite this article as:
Verma Shivani, Utreja Puneet, Rahman Mahfoozur and Kumar Lalit*, Gold Nanoparticles and their Applications in Cancer Treatment, Current Nanomedicine 2018; 8 (3) . https://dx.doi.org/10.2174/2468187308666180312130055
| DOI https://dx.doi.org/10.2174/2468187308666180312130055 |
Print ISSN 2468-1873 |
| Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |
Call for Papers in Thematic Issues
Nanoformulation Toxicity and Safety Challenges in Targeted Drug Delivery Systems
Nano-enabled drug delivery has redefined the landscape of targeted therapy by offering controlled release, enhanced bioavailability, and tissue-specific action. However, the same properties that confer clinical advantages, such as nanoscale size, unique surface chemistry, and multifunctional design, can also introduce unexpected toxicities. This thematic issue, “Nanoformulation Toxicity and Safety Challenges ...read more
Nanomaterials for Drug Delivery System in Chronic and Infectious Disease Therapy
The exploration of nanomaterials for drug delivery systems represents a cutting-edge frontier in modern medical research. In our tThematic Iissue, we delve into the extensive scope of utilizing nanotechnology to combat chronic and infectious diseases. This emerging field holds tremendous promise, offering innovative solutions to longstanding challenges in healthcare. At ...read more
Preclinical Advances of Gold and Silver Nanoparticles: Mechanistic Insights into Anticancer, Antidiabetic, and Neuroactive Applications
Nanomedicine has emerged as one of the most dynamic and promising fields in modern biomedical research, integrating the principles of nanotechnology with medicine to revolutionize disease diagnosis, treatment, and prevention. Recent advancements in nanomaterials and nanocarrier systems have provided unique opportunities to overcome limitations associated with conventional therapeutics, such as ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
Current Pharmaceutical Design Non-Classical Structures Among Current Platinum Complexes with Potential as Antitumor Drugs
Current Topics in Medicinal Chemistry The Role of Diabetes in Molecular Pathogenesis of Cancer
Current Signal Transduction Therapy Anionic Host Defence Peptides from the Plant Kingdom: Their Anticancer Activity and Mechanisms of Action
Protein & Peptide Letters Decreased Expression of Caveolin-1 and E-Cadherin Correlates with the Clinicopathologic Features of Gastric Cancer and the EMT Process
Recent Patents on Anti-Cancer Drug Discovery Integrating the Universe of Effector and Regulatory Immune Cell Subsets: An Emerging Role of Protein-Glycan Interactions
Current Immunology Reviews (Discontinued) Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416
Current Vascular Pharmacology Nanoscale Formulations and Diagnostics With Their Recent Trends: A Major Focus of Future Nanotechnology
Current Pharmaceutical Design Design, Synthesis and Anticancer Activity Against the MCF-7 Cell Line of Benzo-Fused 1,4-Dihetero Seven- and Six-Membered Tethered Pyrimidines and Purines
Current Medicinal Chemistry A Review: Hair Health, Concerns of Shampoo Ingredients and Scalp Nourishing Treatments
Current Pharmaceutical Biotechnology Methodological Issues of Clinical Research with EGFR Inhibitors
Current Cancer Therapy Reviews The Use of Mathematical Modelling for Improving the Tissue Engineering of Organs and Stem Cell Therapy
Current Stem Cell Research & Therapy Stable Expression of the Sodium/Iodide Symporter (NIS) for anti-Cancer Gene Therapy of Glioma Cells Using a Third Generation Self-Inactivating Lentiviral Vector System in Combination with 211At
Current Radiopharmaceuticals Meet Our Co-Editor
Central Nervous System Agents in Medicinal Chemistry On the Importance of Polyurethane and Polyurea Nanosystems for Future Drug Delivery
Current Drug Delivery Effects of Plasma Activated Medium on Head and Neck FaDu Cancerous Cells: Comparison of 3D and 2D Response
Anti-Cancer Agents in Medicinal Chemistry Measles Virus as An Oncolytic Vector Platform
Current Gene Therapy Preface
Clinical Cancer Drugs Regulation of ABC Transporter Function Via Phosphorylation by Protein Kinases
Current Pharmaceutical Biotechnology Protein Phosphatase 1 and Its Complexes in Carcinogenesis
Current Cancer Drug Targets





